Clinical Trial Update: Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma [Phase 2]

View source ↗

Summary

This Phase 2 trial is evaluating neoadjuvant PD-1 blockade before surgical resection in patients with resectable Merkel cell carcinoma and is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Merkel Cell Carcinoma

Drugs mentioned

• PD-1 inhibitor

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Merkel Cell Carcinoma | Phase 2 | Status: RECRUITING